Almac Clinical Services, a subsidiary of Almac Group, has introduced its Tempod 1000 that is claimed to enhance the company's Site Compliance and temperature management offering for sponsors, it was reported on Wednesday.
Intended to augment Almac's established temperature management service, Tempod 1000 is a USB device that captures and stores all clinical site temperature data and automatically finds unreported excursions once uploaded into TempEZ. It is aimed at removing the administrative burden of updating manual temperature logs, increasing site compliance with reporting data and promoting best digital practice in clinical studies and patient safety.
The device will also decrease the risk of missed patient visits due to unreported excursions, enable sponsors and CRAs to identify and resolve excursions remotely, accelerates CRA review time during site visits, and facilitate timely and efficient study close-outs and database locks.
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Implantica's RefluxStop receives US FDA approval
Sectra to provide Education Portal to Loyalist College for medical imaging training
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
Abbott and NACHC launch nationwide Food for Health initiative
Galmed reports positive preclinical results for Aramchol in prostate cancer
Galderma receives EU approval for Restylane Shaype facial shaping injectable
Acarix's CADScor System receives UAE regulatory approval
Amsino receives Vizient contract for enteral syringes
Sisram Medical introduces Titanium Prime treatment concept in Hong Kong SAR